MCID: PYR010
MIFTS: 43

Peyronie's Disease malady

Categories: Rare diseases, Reproductive diseases

Aliases & Classifications for Peyronie's Disease

About this section
Sources:
33MalaCards, 10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 36MeSH, 65UMLS, 27ICD10, 29ICD9CM, 42NCIt, 59SNOMED-CT
See all MalaCards sources

Aliases & Descriptions for Peyronie's Disease:

Name: Peyronie's Disease 33 10 12
Peyronie Disease 10 45 47 65
Balanitis Xerotica Obliterans 65
Induratio Penis Plastica 10
 
Peyronie's Fibromatosis 10
Penile Induration 36
Peyronies Disease 33
Penile Curvature 45

Classifications:



External Ids:

Disease Ontology10 DOID:8616
ICD1027 N48.6
ICD9CM29 607.85
MeSH36 D010411
NCIt42 C3316
UMLS65 C0030848

Summaries for Peyronie's Disease

About this section
NIH Rare Diseases:45 Peyronie disease is a connective tissue disorder characterized by a plaque, or hard lump, that forms within the penis. affected individuals may experience painful, curved erections which can make make normal sexual intercourse impossible. symptoms may appear suddenly or develop gradually. while the painful erections for most men resolve over time, the scar tissue and curvature may remain. some cases appear to resolve spontaneously. the exact cause of peyronie's disease is not known. last updated: 11/23/2011

MalaCards based summary: Peyronie's Disease, also known as peyronie disease, is related to ledderhose disease and keratoconus, and has symptoms including abnormality of the skeletal systemand abnormality of the genitourinary system. An important gene associated with Peyronie's Disease is IFNA2 (Interferon, Alpha 2), and among its related pathways are Type II interferon signaling (IFNG) and NO-dependent CFTR activation (normal and CF). Affiliated tissues include breast, liver and kidney, and related mouse phenotype muscle.

Wikipedia:68 Peyronie\'s disease or Peyronie disease (/peɪroʊˈniː/), also known as induratio penis plastica (IPP)... more...

Related Diseases for Peyronie's Disease

About this section

Diseases related to Peyronie's Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)
idRelated DiseaseScoreTop Affiliating Genes
1ledderhose disease10.4
2keratoconus10.3IFNA2, TGFB1
3hepatitis10.3
4pancreatitis10.3
5listeria meningitis10.3NOS2, SOD1
6early-onset, autosomal dominant alzheimer disease10.3NOS2, SOD1
7nephronophthisis familial adult spastic quadriparesis10.2DCN, TGFB1
8adult t-cell leukemia10.2IFNA2, SOD1
9whipple disease10.2DCN, TGFB1
10secondary corneal edema10.2DCN, TGFB1
11legionellosis10.2NOS2, SOD1
12obesity10.1
13aspergillosis10.1
14pancreatic cancer10.1
15hepatitis b10.1
16morbid obesity10.1
17brugada syndrome10.1
18lymphoma10.1
19renal-hepatic-pancreatic dysplasia10.1
20sialadenitis10.1
21status epilepticus10.1
22splenic infarction10.1
23leydig cell tumor10.1
24sertoli-leydig cell tumor10.1
25aortic coarctation10.1
26wallerian degeneration10.1
27aortic disease10.1NOS2, TGFB1
28gestational diabetes10.1CCL2, NOS2
29gingivitis10.1DCN, TGFB1
30spinal muscular atrophy10.1NOS2, TGFB1
31acrodysostosis10.1PDE5A, TGFB1
32patau syndrome10.1CCL2, TGFB1
33oral candidiasis10.1CCL2, TGFB1
34suppurative uveitis10.1CCL2, TGFB1
35malignant struma ovarii10.0CCL2, TGFB1
36mixed cell type cancer10.0IFNA2, PDE5A, TGFB1
37neurogenic bladder9.9CCL2, NOS2, TGFB1
38exudative vitreoretinopathy 19.9CCL2, TGFB1
39mixed mineral dust pneumoconiosis9.9CCL2, SOD1, TGFB1
40thyroid cancer9.9CCL2, NOS2, SOD1
41acute interstitial pneumonia9.9CCL2, TGFB1
42ectopia lentis, familial9.8DCN, TGFB1
43pulmonary hypertension8.0ACTG2, CCL2, DCN, IFNA2, MSTN, NOS2

Graphical network of the top 20 diseases related to Peyronie's Disease:



Diseases related to peyronie's disease

Symptoms for Peyronie's Disease

About this section

HPO human phenotypes related to Peyronie's Disease:

id Description Frequency HPO Source Accession
1 abnormality of the skeletal system HP:0000924
2 abnormality of the genitourinary system HP:0000119

Drugs & Therapeutics for Peyronie's Disease

About this section

Drugs for Peyronie's Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 40)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SevelamerapprovedPhase 372152751-57-03085017
Synonyms:
Renagel
Renvela
Sevelamer
Sevelamer Carbonate
 
Sevelamero
Sevelamerum
Sévélamer
sevelamer carbonate
sevelamer hydrochloride
2Chelating AgentsPhase 3667
3
AcetylcholineexperimentalPhase 268951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
4Neurotransmitter AgentsPhase 214795
5OnabotulinumtoxinAPhase 2588
6Peripheral Nervous System AgentsPhase 218510
7Neuromuscular AgentsPhase 2922
8Pharmaceutical SolutionsPhase 27004
9IncobotulinumtoxinAPhase 2599
10AbobotulinumtoxinAPhase 2588
11Botulinum ToxinsPhase 2616
12Botulinum Toxins, Type APhase 2588
13Cholinergic AgentsPhase 23243
14
MethyltestosteroneapprovedPhase 147458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
15
Testosteroneapproved, investigationalPhase 147458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
16
Ergocalciferolapproved, nutraceuticalPhase 192350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
17
Vitamin Eapproved, nutraceuticalPhase 137159-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-alpha-tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-ol
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'r)-alpha-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-alpha-tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitamin e
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
d-alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
18Testosterone 17 beta-cypionatePhase 1474
19Testosterone undecanoatePhase 1474
20
Testosterone enanthatePhase 1474315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
21Trace ElementsPhase 13900
22VitaminsPhase 13857
23vitamin dPhase 11524
24TocotrienolsPhase 1372
25TocopherolsPhase 1376
26ErgocalciferolsPhase 1923
27MicronutrientsPhase 13901
28Bone Density Conservation AgentsPhase 12600
29Antineoplastic Agents, HormonalPhase 14256
30AndrogensPhase 11162
31Hormone AntagonistsPhase 110002
32Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 19988
33HormonesPhase 111748
34Anabolic AgentsPhase 1375
35Vitamin D2NutraceuticalPhase 1923
36CalciferolNutraceuticalPhase 11074
37TocotrienolNutraceuticalPhase 1372
38TocopherolNutraceuticalPhase 1376
39Phosphodiesterase 5 Inhibitors513
40Mitogens1386

Interventional clinical trials:

(show all 19)
idNameStatusNCT IDPhase
1Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies DiseaseActive, not recruitingNCT02298829Phase 4
2Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221597Phase 3
3A Study of AA4500 in Men With Peyronie's DiseaseCompletedNCT01243411Phase 3
4Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221623Phase 3
5A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's DiseaseCompletedNCT01685437Phase 3
6An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's DiseaseActive, not recruitingNCT02267460Phase 3
7A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
8The Safety and Effectiveness of AA4500 in Subjects With Peyronie's DiseaseCompletedNCT00755222Phase 2
9Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's DiseaseCompletedNCT01430169Phase 2
10H-22411: BOTOX® for Peyronie's DiseaseRecruitingNCT00812838Phase 2
11Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)RecruitingNCT01184586Phase 2
12Peyronie's Disease Treatment ProtocolCompletedNCT02072018Phase 1
13Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PDCompletedNCT02395029Phase 1
14Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's DiseaseActive, not recruitingNCT01578473Phase 1
15Change in Penile Length Following Bilateral Nerve-Sparing Radical ProstatectomyCompletedNCT00800813
16Management of Peyronie's Disease With Adipose Tissue Stem CellRecruitingNCT02414308
17Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary ConditionsRecruitingNCT01953523
18Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014RecruitingNCT01503034
19Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain SyndromeActive, not recruitingNCT01714830

Search NIH Clinical Center for Peyronie's Disease


Cochrane evidence based reviews: penile induration

Genetic Tests for Peyronie's Disease

About this section

Anatomical Context for Peyronie's Disease

About this section

MalaCards organs/tissues related to Peyronie's Disease:

33
Breast, Liver, Kidney, Prostate, Endothelial, Heart, Lung

Animal Models for Peyronie's Disease or affiliated genes

About this section

MGI Mouse Phenotypes related to Peyronie's Disease:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.0DCN, MSTN, NOS2, SOD1, TGFB1

Publications for Peyronie's Disease

About this section

Articles related to Peyronie's Disease:

(show top 50)    (show all 571)
idTitleAuthorsYear
1
Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study. (27131759)
2016
2
MTHFR gene polymorphism and risk of myeloid leukemia: a meta-analysis. (24894669)
2014
3
Plasma From Patients With HELLP Syndrome Increases Blood-Brain Barrier Permeability. (25194151)
2014
4
Prophylactic strategies in recurrent vulvovaginal candidiasis: a 2-year study testing a phytonutrient vs itraconazole. (24152852)
2013
5
Presence of C11orf95-MKL2 fusion is a consistent finding in chondroid lipomas: a study of eight cases. (23672313)
2013
6
Revenge and forgiveness or betrayal blindness? (23211413)
2013
7
Generation of leukemia inhibitory factor-dependent induced pluripotent stem cells from the massachusetts general hospital miniature pig. (24371815)
2013
8
A review of the burden of disease due to otitis media in the Asia-Pacific. (22404948)
2012
9
Barrett's Esophagus: Emerging Knowledge and Management Strategies. (22701199)
2012
10
Thoracoscopic treatment of congenital esophageal stenosis in combination with H-type tracheoesophageal fistula. (22901927)
2012
11
Odontoma-associated tooth impaction: accurate diagnosis with simple methods? Case report and literature review. (22883320)
2012
12
Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. (21881594)
2012
13
Aspergillus fumigatus scleritis associated with monoclonal gammopathy of undetermined significance. (20532146)
2010
14
CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice. (20551902)
2010
15
Characterization of a subpopulation of colon cancer cells with stem cell-like properties. (19072981)
2009
16
Asymmetric tethering of flat and curved lipid membranes by a golgin. (18451304)
2008
17
High frequency of p16 promoter methylation in non-small cell lung carcinomas from Chile. (18449464)
2007
18
Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease. (17537900)
2007
19
Signaling mechanisms involved in disuse muscle atrophy. (17376604)
2007
20
Osteoprotegerin--does it play a protective role in the pathogenesis of bone loss in obese perimenopausal women? (17354199)
2007
21
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. (15652749)
2005
22
Inclusion of Scar/WAVE3 in a similar complex to Scar/WAVE1 and 2. (15752430)
2005
23
Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility. (16126774)
2005
24
MA1llerian tumor (atypical polypoid adenomyoma) with sex-cord differentiation arising from the oviduct in an adolescent cynomolgus monkey (Macaca fascicularis). (12696577)
2003
25
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. (14583454)
2003
26
Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study. (14736075)
2003
27
A rare case of cellular schwannoma involving the trigeminal ganglion. (14756445)
2003
28
Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity. (11595479)
2001
29
Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility. (11641688)
2001
30
The benefits of niacin in atherosclerosis. (11123852)
2001
31
Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. (10803601)
2000
32
Cemento-ossifying fibroma presenting as a mass of the parapharyngeal and masticator space. (10543652)
1999
33
Eradication of trachoma worldwide. (10535853)
1999
34
Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan. (9586576)
1998
35
Cell signaling pathways elicited by asbestos. (9400710)
1997
36
Antiabsence seizure activity of specific GABAB and gamma-Hydroxybutyric acid receptor antagonists. (8848463)
1996
37
Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. (8921363)
1996
38
Effect of expression of human spermidine/spermine N1-acetyltransferase in Escherichia coli. (7873553)
1995
39
Presence of MRP8 and MRP14 in pancreatic cell lines: differential expression and localization in CFPAC-1 cells. (7762618)
1995
40
Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study. (8174205)
1994
41
Regulation of chemokine production by the oxidative metabolism of L-arginine in a human mixed lymphocyte reaction. (8200045)
1994
42
Recombinant alpha-interferon 2b in the treatment of HIV-related thrombocytopenia. (8363758)
1993
43
Prophylaxis during surgery in antithrombin III deficiency with low dose of concentrates. (2617483)
1989
44
Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship. (2789173)
1989
45
Epidemiological aspects of a St. Louis encephalitis outbreak in Harris County, Texas, 1986. (2891777)
1988
46
Intestinal perforation in typhoid fever: a historical and state-of-the-art review. (3890098)
1985
47
Pathology of Herpes Simplex Kerato-Iritis. (16693633)
1963
48
Histochemical studies in cytomegalic inclusion disease. (13091582)
1953
49
50

Variations for Peyronie's Disease

About this section

Expression for genes affiliated with Peyronie's Disease

About this section
Search GEO for disease gene expression data for Peyronie's Disease.

Pathways for genes affiliated with Peyronie's Disease

About this section

GO Terms for genes affiliated with Peyronie's Disease

About this section

Biological processes related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of T cell proliferationGO:004213010.3PDE5A, TGFB1
2positive regulation of MAP kinase activityGO:004340610.2PDE5A, TGFB1
3positive regulation of collagen biosynthetic processGO:003296710.1CCL2, TGFB1
4negative regulation of myoblast differentiationGO:004566210.0MSTN, TGFB1
5cellular response to organic cyclic compoundGO:007140710.0CCL2, TGFB1
6organ regenerationGO:003110010.0CCL2, TGFB1
7positive regulation of superoxide anion generationGO:003293010.0SOD1, TGFB1
8positive regulation of pathway-restricted SMAD protein phosphorylationGO:00108629.9MSTN, TGFB1
9cellular response to drugGO:00356909.9CCL2, NOS2
10growthGO:00400079.9MSTN, TGFB1
11response to progesteroneGO:00325709.9CCL2, TGFB1
12response to woundingGO:00096119.9CCL2, TGFB1
13negative regulation of angiogenesisGO:00165259.8CCL2, DCN
14response to bacteriumGO:00096179.8CCL2, NOS2
15lipopolysaccharide-mediated signaling pathwayGO:00316639.8CCL2, TGFB1
16cellular response to interferon-gammaGO:00713469.7CCL2, NOS2
17response to antibioticGO:00466779.6CCL2, SOD1
18inflammatory responseGO:00069549.5IFNA2, NOS2, TGFB1
19superoxide metabolic processGO:00068019.5NOS2, SOD1
20blood coagulationGO:00075969.2IFNA2, SOD1, TGFB1
21response to heatGO:00094089.0CCL2, MSTN
22transforming growth factor beta receptor signaling pathwayGO:00071799.0CCL2, MSTN, TGFB1
23cellular response to dexamethasone stimulusGO:00715498.9CCL2, MSTN, TGFB1
24response to drugGO:00424938.7CCL2, SOD1, TGFB1
25agingGO:00075688.5CCL2, DCN, SOD1, TGFB1

Sources for Peyronie's Disease

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet